Wellsheet Granted Patent to Make Electronic Health Records User-Friendly
Intuitive and Predictive Workflow App for EHR:
• Reduces time spent in the EHR, which reduces physician burnout
• Reduces training time and improves productivity
• Increases clinician satisfaction by an order of magnitude
Venatorx Pharmaceuticals Announces Positive Phase 1 Results for VNRX-7145
Investigational oral beta-lactamase inhibitor VNRX-7145 was well-tolerated with no safety signals up to the highest dose as a single agent
Ceftibuten/VNRX-7145 Combination Phase 1 Study Initiated with Top Line Results Expected Fourth Quarter 2021
Company Plans to Initiate Phase 3 Clinical Trial for Ceftibuten/VNRX-7145 in Second Half 2022
ImmunoGenesis Expands R&D, Clinical and Business Development Teams and Opens Research Laboratory
Clinical and CMC hires to ready initiation of multiple immuno-oncology clinical programs in 2022
Proven business development expertise key to executing global clinical development strategy
R&D hires and lab opening to facilitate critical translational research
Annovis Bio Reports Positive Safety Data from its Phase 2 Alzheimer’s Study
Safety and tolerability data for Cohort 2 of the Discover Study reviewed by Data Safety Monitoring Board, allowing the study to proceed with the final cohort
Relmada Therapeutics Announces the Acquisition of Development and Commercial Rights to Novel Psilocybin and Derivates Program from Arbormentis LLC
Ride Health and the American Heart Association Partner to Improve Health Equity for Patients Facing Transportation Barriers
American Heart Association’s Social Impact Fund and Bernard J. Tyson Impact Fund invest $500,000 to support comprehensive patient transportation programs at renowned hospitals
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing
– IMM-BCP-01 already shown to neutralize all other CDC variants of concern in pre-clinical testing
– IND submission planned for this quarter
CrossBridge Health acquires Geisinger-developed PACER software
CrossBridge to integrate PACER intelligence to improve outcomes for patients with chronic inflammatory diseases
Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance
Dr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapy
Envara Health Named Winner of 2021 PACT Enterprise Awards
Nutrition Company Redefining ‘Food as Medicine’ Recognized for Commitment to Science-Backed Technology in the Life Sciences Industry